Ligand Pharmaceuticals: Q2 Earnings Insights

Ligand Pharmaceuticals LGND reported its Q2 earnings results on Monday, August 8, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Ligand Pharmaceuticals reported an EPS of $1.03.

Revenue was down $27.26 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.1 which was followed by a 5.54% drop in the share price the next day.

Here's a look at Ligand Pharmaceuticals's past performance:

To track all earnings releases for Ligand Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.